What is Restorative Reproductive Medicine (RRM)?

What Is Restorative Reproductive Medicine?

Restorative Reproductive Medicine (RRM) is a field of medicine that diagnoses and treats the underlying conditions causing reproductive health problems in women and men. RRM identifies the specific cause and treats it. The goal is a body functioning at its healthy physiologic state.

RRM addresses endometriosis, PCOS, ovulatory dysfunction, recurrent miscarriage, pelvic pain, hormonal dysfunction, male factor conditions, and perimenopause. A teenager with worsening periods, a woman with PMDD, a couple struggling to conceive, a man with low testosterone: all are RRM patients. Fertility is one outcome of a body restored to healthy function. The field covers reproductive health across the lifespan.

Three Core Principles

1. Find the cause. Every evaluation begins with the question: what is producing these symptoms? RRM uses cycle-timed diagnostics, imaging, and targeted lab work to identify the specific condition. The workup does not stop at "unexplained."
2. Treat the disease. Treatment is matched to the diagnosis. Hormonal support, surgery, metabolic intervention, or a combination, each targeted to the finding. Nothing is empiric. Nothing is generic.
3. Restore function. The goal is a body working as it should. When the disease is treated, reproductive function (including fertility, cycle regularity, hormonal balance, and pain resolution) often returns on its own.

Who Practices RRM?

OBGYNs, family medicine clinicians, nurse practitioners, midwives, physician assistants, naturopaths, nutritionists, pelvic floor therapists, and FertilityCare practitioners all work within the RRM model. They use the same tools as any specialist: bloodwork, imaging, surgery, and pharmacology. What makes RRM distinct is the clinical logic. RRM clinicians time interventions to the patient's cycle and target them to a specific diagnosis. It is medicine applied with more information.⁶²⁶

RRM clinicians come from varied backgrounds and serve patients and couples of all faiths and none. The science does not depend on any religious framework.²

Is RRM Evidence-Based?

RRM is supported by peer-reviewed research published in Fertility and Sterility, The Journal of the American Board of Family Medicine, Frontiers in Medicine, and the Journal of Restorative Reproductive Medicine. The RRM Academy Research Library indexes over 3,000 peer-reviewed publications.³⁴

What Question Does RRM Ask?

RRM asks a different question than most reproductive medicine: what is the cause, and can it be treated? That question drives every evaluation, every diagnostic decision, and every treatment plan. It is the organizing principle of the field.

Clinicians who want to practice RRM can pursue training through RRM Academy, IIRRM credentialing, FACTS About Fertility, FEMM's Reproductive Health Research Institute (RHRI), or NaProTechnology fellowship programs.

The History of Restorative Reproductive Medicine

RRM is a growing field of medicine with clinicians practicing internationally, dedicated training programs, a peer-reviewed journal, and a body of research that is still expanding. The field has been advancing for over 70 years, built from a single insight: the menstrual cycle produces daily biomarkers that can diagnose reproductive disease. That insight led to clinical protocols, surgical advances, and outcome data that makes the case for moving beyond symptom suppression toward investigating and treating the conditions themselves.

The Foundations: Cycle Science as Diagnostics (1950s-1970s)

The diagnostic power of RRM rests on science that began with a question: what can the menstrual cycle tell us about a woman's health? Swedish physician Dr. Erik Odeblad used nuclear magnetic resonance in the 1950s to identify distinct types of cervical mucus and map their roles in reproductive function. His biophysical research established that cervical fluid is not a single substance but a complex, hormonally responsive system. That foundational science informed every charting method that followed.

Drs. John and Evelyn Billings in Melbourne, Australia, built on this work, establishing that cervical mucus patterns reflect underlying hormonal activity and can be observed by women themselves in real time.⁸ This was a key clinical insight: the female body produces observable, measurable biomarkers that track its reproductive status daily. While fertility awareness was the first application, the deeper implication was diagnostic. Abnormal patterns meant something was wrong.

Researchers had also identified other biomarkers beyond cervical mucus: basal body temperature shifts that confirm ovulation has occurred, and changes in cervical position that correlate with hormonal phases. John and Sheila Kippley, with the help of Dr. Ronald Prem, founded the Couple to Couple League (CCL) in 1971 to teach the first symptoms-based method that combined all three signs into a single system. The SymptoThermal Method became the most widely taught natural family planning method in the United States, reaching thousands of couples and establishing chapters in over 20 countries. Its multi-indicator approach demonstrated that combining biomarkers produced more clinically useful data than any single sign alone. RRM clinicians still apply that principle.

Dr. Thomas Hilgers at Creighton University took the next step, developing the Creighton Model FertilityCare System (CrMS) starting in 1976. CrMS standardized the observation and recording of cervical mucus biomarkers into a rigorous, teachable system. Hilgers recognized that the daily charting data revealed patterns that correlated with specific reproductive disorders. Abnormal bleeding, shortened luteal phases, and disrupted mucus cycles were not random. They were diagnostic signals.⁹

From Charting to Clinical Medicine (1980s-1990s)

The charting methods had matured enough to ask a bigger question: could daily biomarker data guide medical diagnosis and treatment? The clinicians developing these systems believed it could.

Dr. Hilgers founded the Saint Paul VI Institute for the Study of Human Reproduction in Omaha, Nebraska in 1985. The institute conducted what became one of the most detailed prospective research programs on female reproductive hormones, tracking women's cycles over decades.⁹

The result was NaProTechnology (Natural Procreative Technology), the first complete medical and surgical system built on cycle charting data. Clinicians trained at the institute learned to read the cycle chart the way a cardiologist reads an EKG, detecting patterns that pointed to specific conditions: endometriosis, PCOS, luteal phase deficiency, ovulatory dysfunction, and hormonal imbalance. The goal was to work with the cycle to restore healthy function, not to override it.

NaProTechnology established that cycle-informed medicine could produce measurable clinical outcomes. The institute continues to publish research and train clinicians. Other clinicians and researchers applied the same foundational principles in different clinical settings, and the field expanded.

Expanding the Field (2000s-2010s)

The vision was to unite all providers of restorative reproductive medicine, regardless of which charting method they used. That vision took shape starting in November 2000, when clinicians from Canada, Ireland, and the United Kingdom began formal discussions. Representatives from Australia and the United States joined subsequent meetings, resulting in the creation of the International Institute for Restorative Reproductive Medicine (IIRRM).¹

Dr. Joseph Stanford, a family physician and researcher at the University of Utah, joined as a board member and helped develop RRM-focused clinical models. The IIRRM became the leading voice in advancing RRM through mentorship, education, and collaboration, centering on the belief that patients deserve scientifically based reproductive health care that cooperates with and restores reproductive function.

Several approaches developed during this period:

• FACTS About Fertility (2010), co-founded by family physicians Dr. Marguerite Duane and Dr. Bob Motley, began educating medical students and physicians about the evidence supporting FABMs and RRM.⁵
• FEMM (2012) and its research arm, the Reproductive Health Research Institute (RHRI), introduced hormonal health protocols combining fertility charting with medical management. Over 1,500 medical providers have been trained.⁶
• NeoFertility (2016), developed by Dr. Phil Boyle in Ireland, expanded treatment options to address autoimmune and inflammatory conditions alongside hormonal imbalances.¹⁰

Surgical outcomes advanced as well: Dr. Patrick Yeung's RESTORE Center achieved a 2.5% repeat-surgery rate for endometriosis excision over ten years,¹¹ compared to recurrence rates as high as 40% within five years after ablation.³⁹

Growing Recognition (2015-Present)

Dr. Naomi Whittaker and Brian Whittaker launched By Its Fruit in 2015, an early curated online library of RRM research, to answer a question patients kept asking: "Why have I never heard about this before?" Dr. Whittaker's clinical education on social media via @napro_fertility_surgeon starting in 2018 built a following that led to the founding of the RRM Foundation and RRM Academy in 2023, a nonprofit offering free courses, a peer-reviewed research library, and physician-authored guides.

The field gained its own peer-reviewed publication in 2025 with the launch of the Journal of Restorative Reproductive Medicine, an open-access journal published by IIRRM with Dr. Joseph Stanford as Editor-in-Chief.²³ The inaugural volume included the first head-to-head RRM-versus-IVF comparison.²⁴

Recognition followed the outcomes. The New York Times, STAT News, The 19th, and OSV News all covered RRM for the first time in 2025. Arkansas became the first U.S. state to mandate insurance coverage for restorative reproductive medicine, and the RESTORE Act (H.R. 3589) was introduced in Congress to expand access.

Today, RRM-trained clinicians practice internationally.² The field's growth is no longer driven by a single institution or protocol. It is driven by outcome data, patient demand, and a couple-centric approach to care that treats patients as active participants in understanding and improving their own health.

How RRM Diagnosis Works

RRM diagnosis is a systematic evaluation designed to identify the underlying condition causing a patient's reproductive health symptoms. Where conventional approaches often manage symptoms with suppressive medications, RRM asks what is producing those symptoms and builds a diagnostic workup to find it. The goal is a specific, named diagnosis that directs treatment.

The Cycle Chart: Diagnostic Foundation

The cycle chart is a clinical instrument that captures hormonal patterns across the full menstrual cycle: mucus quality, ovulation timing, luteal phase length, premenstrual patterns, and bleeding characteristics. For a teenager with progressively worsening periods, the chart reveals patterns that a single office visit cannot. For a woman with cycle irregularity entering perimenopause, it captures changes over time. These daily observations direct every subsequent test.

Cycle-Timed Hormonal Evaluation

Hormonal evaluation in RRM is cycle-timed, not calendar-based. Conventional workups often measure a few hormones on an arbitrary calendar day. RRM orders serial bloodwork timed to specific phases of the individual's cycle, capturing hormonal curves that a single draw misses entirely. That precision is what allows RRM to identify conditions like luteal phase deficiency, subtle ovulatory dysfunction, or thyroid-related cycle disruption that standard panels consistently overlook.

Structural Evaluation

Structural evaluation follows the hormonal picture. Pelvic imaging assesses uterine anatomy. When history or chart data points to endometriosis, diagnostic laparoscopy is the definitive next step. Many patients arrive having been told their imaging was "normal." Laparoscopy finds the disease that imaging cannot see.

Male Factor Evaluation

For couples presenting with infertility, male factor evaluation is standard. A male factor is solely responsible in approximately 20% of infertile couples and contributory in another 30 to 40%.²⁷ Semen analysis is the baseline. When abnormalities appear, RRM investigates the cause: hormonal imbalances, varicocele, infection, or oxidative stress. Restorative andrology aims to treat the underlying condition, not bypass it.

The Diagnostic Difference

Diagnoses labeled "unexplained" rarely survive a complete RRM workup. In Boyle et al. (2025), the "unexplained" category dropped from 24% of couples at presentation to just 1% after full evaluation.²⁴ The diagnosis was not missing. The evaluation to find it was.

What Role Do Fertility Awareness Methods Play in RRM?

In RRM, fertility awareness-based methods are clinical diagnostic instruments. A well-charted cycle gives the clinician daily biomarker data that reveals hormonal patterns invisible to a single blood draw or office visit. The American College of Obstetricians and Gynecologists recognized the menstrual cycle as a vital sign in 2015.¹⁴ FABMs are how RRM captures that vital sign in detail.⁶

What Does a Cycle Chart Reveal?

A cycle chart records daily observations: cervical mucus characteristics, bleeding patterns, and (depending on the method) basal body temperature and urinary hormone levels. When trained clinicians read this data, patterns emerge:

• Limited cervical mucus may indicate low estrogen
• A short post-ovulatory phase suggests inadequate progesterone
• Premenstrual spotting can signal hormonal imbalance
• Long or irregular cycles may point to PCOS or ovulatory dysfunction

These are specific biomarker signals that direct further testing.⁹

Major FABMs Used in RRM

*The Creighton Model FertilityCare System is classified by its developers as natural family planning (NFP), not as a fertility awareness-based method. It is included here because it serves the same diagnostic function in RRM clinical practice.

Choosing a Method

No single charting method is best for every woman. Women with PCOS or irregular cycles may benefit from the Marquette Method's objective hormonal monitoring. Women seeking the most direct connection to NaProTechnology diagnosis typically choose the Creighton Model. SymptoThermal methods offer the redundancy of multiple biomarkers. What matters most is that the method is learned from a trained instructor and charted consistently. The diagnostic value comes from the data.

Body Literacy and Early Detection

Charting is valuable for any woman at any stage of reproductive life, whether or not conception is the goal. Charting builds body literacy: an understanding of hormonal health that enables women and couples to recognize when something changes. A cycle that was regular and suddenly becomes irregular is a signal. Premenstrual symptoms that worsen over time are a signal. These signals, captured on a chart, give clinicians actionable data and give patients an active role in their own healthcare.⁶

As Dr. Naomi Whittaker has described it, practicing reproductive medicine without cycle chart data is "flying blind."⁷

Conditions Treated with Restorative Reproductive Medicine

RRM addresses a wide range of reproductive health conditions by diagnosing and treating the underlying cause. The table below describes typical approaches used in RRM care. Every treatment plan is individualized. This information is educational, not prescriptive.

How Does RRM Treat Endometriosis?

Endometriosis affects an estimated 10% of reproductive-age women. The median time from symptom onset to diagnosis is nine years.¹³ During those years, the disease progresses. Adhesions form. Pain worsens. Many women are told their symptoms are normal.

The conventional approach relies on suppressive medications to manage pain without treating disease progression. Neither suppression nor bypassing the disease addresses the endometriosis itself.

RRM uses minimally invasive excision surgery, which removes endometriosis tissue at the root rather than burning the surface. This distinction matters. Ablation causes thermal damage and leaves deeper disease behind. Yeung et al. reported a 2.5% repeat surgery rate over ten years after excision,¹¹ compared to recurrence rates as high as 40% within five years after ablation.³⁹

Effective excision includes adhesion prevention protocols that preserve pelvic anatomy and reproductive function. Endometriosis is a chronic condition, and post-operative care (hormonal support, cycle monitoring, long-term management) must account for that. If you suspect endometriosis, our Endometriosis Self-Survey can help you assess your symptoms.

How Does RRM Treat PCOS?

PCOS affects 6-12% of reproductive-age women and is the most common endocrine disorder in this population. Not all PCOS is the same. RRM evaluates by phenotype: insulin-resistant, inflammatory, adrenal, or post-pill. Each requires a different treatment strategy.

Cycle charting reveals the specific ovulatory dysfunction present. Some women ovulate irregularly. Others do not ovulate at all. The chart data guides the clinician to the correct intervention matched to the individual's pattern.⁵

What Does RRM Do About "Unexplained" Infertility?

"Unexplained infertility" is a label, not a diagnosis.²⁹ It means the standard workup did not find the cause. RRM reframes this as "not yet diagnosed" and begins a more thorough investigation.

A cause is almost always found. Many have undiagnosed endometriosis. Others have luteal phase deficiency detectable only through serial post-ovulatory testing. Some have subtle ovulatory dysfunction visible only on a well-charted cycle. RRM insists on answering the question: why can this couple not conceive? Only then does treatment begin.⁶

How Does RRM Investigate Recurrent Miscarriage?

Recurrent pregnancy loss affects approximately 2 to 5% of couples. The conventional workup includes karyotyping, antiphospholipid antibody testing, and uterine imaging. When these return normal, couples are often told to "keep trying" without further investigation.

RRM expands the investigation. Progesterone support is timed to the ovulatory event identified on the cycle chart, not an arbitrary calendar date. Serial post-ovulatory progesterone measurement identifies luteal phase deficiency that a single draw misses. Full thyroid evaluation, immune workup, and anatomical assessment are standard. The goal is to identify and treat the cause of pregnancy loss.⁴

How Does RRM Address Ovulatory Dysfunction?

Ovulatory dysfunction includes anovulation, infrequent ovulation, and luteal phase deficiency. Cycle charting is the key diagnostic tool. It reveals whether ovulation is occurring, when, and whether the post-ovulatory phase is adequate. Treatment is targeted to the specific finding and monitored cycle by cycle.⁹

How Does RRM Treat Male Factor Infertility?

A male factor is solely responsible in about 20% of infertile couples and contributory in another 30 to 40%.²⁷ Male reproductive health is often undertreated. RRM investigates the cause: hormonal imbalances, varicocele, infections, oxidative stress, metabolic factors. Treatment targets the specific finding. The goal is to restore sperm quality and treat the man's health, not just achieve a pregnancy.¹²

What Does RRM Do for Irregular Periods and Pelvic Pain?

These are symptoms, not diagnoses. Each one signals an underlying condition that deserves investigation. The conventional approach too often skips that step, prescribing suppressive medications that eliminate the cycle and hide the disease. When the medication stops, symptoms return, often worse, because the condition was never treated.⁷

How Does RRM Treat PMS and PMDD?

PMDD and severe PMS cause significant suffering. RRM evaluates hormonal levels across the cycle. Progesterone deficiency, estrogen-progesterone imbalance, and thyroid dysfunction are commonly identified contributors. Treatment uses targeted hormonal support matched to the specific deficiency, not blanket suppression.⁹

Does RRM Help with Perimenopause and Menopause?

RRM does not end at fertility. The same diagnostic framework that identifies hormonal imbalances during the reproductive years applies to the menopausal transition. Cycle charting tracks the changes: lengthening cycles, erratic ovulation, declining progesterone. Because RRM has established each woman's hormonal baseline through years of charted data, the transition to perimenopausal care is informed by a longitudinal record most conventional practices do not have.

Whole-Body, Couple-Centered Care

RRM is not limited to surgical and hormonal intervention. When the clinical picture calls for it, the diagnostic workup and treatment plan can extend to:

• Nutritional and metabolic evaluation: insulin resistance, inflammatory markers, thyroid cofactors, and oxidative stress are assessed and addressed as part of the diagnostic workup
• Mental health support: treated as a clinical reality, not a secondary concern
• Environmental and lifestyle factors: treated as modifiable contributors to reproductive health
• Couple-centered care: both partners are evaluated and involved in treatment. The charting process creates shared understanding and a framework for communication

Clinicians who want to practice RRM can pursue training through RRM Academy, IIRRM credentialing, FACTS About Fertility, FEMM's Reproductive Health Research Institute (RHRI), or NaProTechnology fellowship programs.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.

RRM vs. IVF: A Detailed Comparison

The Fundamental Difference

RRM and IVF answer different questions. IVF asks: how do we get an embryo to implant? RRM asks: why isn't this couple conceiving, and what can be treated?

That distinction is not semantic. IVF bypasses the couple's reproductive physiology entirely. Eggs are retrieved. Sperm is combined in a laboratory. The resulting embryo is transferred into the uterus. Whether the woman ovulates normally, whether her progesterone is adequate, whether she has undiagnosed endometriosis: none of it changes the IVF procedure. The body's function is made irrelevant.

RRM does the opposite. Every test targets a specific diagnostic question. Every treatment is matched to a finding. When the underlying condition is resolved, conception can occur naturally. The technology is applied to diagnose and restore, not to replace.

The core narrative that IVF implicitly transmits is: your body is broken, nature has failed, technology must take over. RRM begins from a different premise: find out what is wrong, treat it, and see what the body can do.

RRM addresses the full spectrum of reproductive health: infertility, endometriosis, hormonal disorders, recurrent miscarriage, pelvic pain, and perimenopause. For the purposes of comparing RRM to IVF, the relevant domain is fertility. That is where the two approaches meet directly, and where the published evidence speaks most clearly.

Side-by-Side Comparison

The Cost Difference

IVF costs $15,000 to $30,000 per cycle in the United States. Most couples need two to three cycles to achieve a live birth, bringing average total spending to $40,000 to $60,000 or more. Add-ons such as genetic testing (PGT-A), ICSI, and frozen embryo transfers push costs higher.¹⁵

RRM costs less, though the exact difference depends on diagnosis, treatment complexity, and what insurance will cover. Because RRM treats diagnosed medical conditions, some components can be submitted to insurance as treatment for those conditions rather than as "fertility treatment." In practice, coverage varies widely by plan, state, and insurer. Not every component is covered, and navigating reimbursement takes persistence. The structural difference is that RRM's diagnostic and therapeutic model opens billing pathways that a bypass procedure like IVF does not, but patients should not assume coverage will be straightforward.

Obstetric Outcomes

How pregnancies are achieved matters, not only whether they occur.

RRM pregnancies result from natural conception. They are almost exclusively singletons. In Boyle et al. (2025), the preterm delivery rate for RRM singletons was 4.0%.²⁴ CDC population data puts IVF singleton prematurity at 11.8%. SART-reported IVF singletons run 14.4%.³⁰ That is a three- to four-fold difference in prematurity risk, with lifelong consequences for the child.

Multiple gestation, more common with IVF, carries elevated rates of preterm birth, low birth weight, cerebral palsy, and neonatal death. Even singleton IVF pregnancies carry higher rates of adverse outcomes compared to naturally conceived singletons. Bewley et al. documented elevated risks of ectopic pregnancy, preeclampsia, placenta previa, and cesarean delivery in IVF-conceived pregnancies.¹⁹

The IVF Evidence Gap

IVF became standard of care without the rigorous evidence evaluation now demanded of newer approaches.

A 2023 Cochrane review identified only two randomized controlled trials comparing IVF to expectant management, enrolling a combined 86 women.³³³⁴ The per-cycle live birth rate for fresh non-donor IVF cycles declined from approximately 30% in 2010 to 22% by 2016, despite decades of adoption.³¹³²

For PCOS and endometriosis, two of the most common diagnoses in the infertility population, published clinical guidelines contain zero RCTs comparing IVF to other management strategies.³⁵ The evidence standard that IVF's advocates invoke against RRM was never applied to IVF itself.

The 2025 institutional position papers opposing RRM cited zero peer-reviewed RRM outcome studies. Patients and providers deserve access to the actual published data, not a characterization of the field that ignores it.

RRM After Failed IVF

RRM is sought by many couples after IVF has already failed. The pattern is consistent: IVF attempted the bypass. RRM finds the underlying condition the bypass never addressed.

Boyle et al. (2018) followed 403 couples who had undergone an average of 2.1 prior IVF attempts.¹⁷ After RRM evaluation and treatment, 32.1% achieved a live birth through natural conception. Of 74 live births, 92% were born at 37 or more weeks gestation. Only one was a twin.

Boyle et al. (2022) documented a couple with 16 years of infertility and eight failed IVF embryo transfers.¹⁰ RRM evaluation identified and treated the underlying conditions. A healthy singleton pregnancy followed. The IVF process never found or treated the cause.

Outcomes vary by individual. All statistics cited represent published research averages, not guarantees of individual results.

Is Restorative Reproductive Medicine Evidence-Based?

RRM is supported by peer-reviewed research published in indexed journals including the Journal of the American Board of Family Medicine, Canadian Family Physician, the Journal of Medical Case Reports, Frontiers in Medicine, and Fertility and Sterility. The RRM Academy Research Library indexes over 3,000 peer-reviewed publications relevant to the science underlying RRM: reproductive endocrinology, surgical outcomes, fertility awareness-based methods, and the conditions RRM clinicians diagnose and treat.

Published RRM outcome studies report crude live birth rates of 26 to 41% and adjusted cumulative rates as high as 62.1% at 36 months. The evidence base includes prospective cohort studies, the first head-to-head RRM-versus-IVF comparison, and the largest NaProTechnology cohort study to date. The research also documents significant advantages in obstetric safety, cost, and diagnostic precision.

What Do the RRM Outcome Studies Show?

Stanford et al. (2008) published a landmark NaProTechnology outcomes study in the Journal of the American Board of Family Medicine. This prospective cohort study followed couples treated with NaProTechnology in an Irish general practice. Among couples with infertility treated over 24 months, the study reported a crude live birth rate of 25.5% and a Kaplan-Meier adjusted cumulative rate of 52.8%. Younger women and those with lower BMI had the highest success rates. The study also documented improvements in gynecological health independent of pregnancy outcomes.³

Tham et al. (2012) studied NaProTechnology outcomes at a Canadian family practice and published results in Canadian Family Physician. Among couples with infertility, 38% achieved at least one live birth. Among women with recurrent miscarriage, those treated with RRM protocols had significantly improved outcomes compared to their prior pregnancy histories. The study demonstrated that RRM can be effectively delivered in a primary care setting, not only in specialized fertility clinics.⁴

Stanford et al. (2021) published a peer-reviewed study in BMC Pregnancy and Childbirth covering two New England family medicine clinics. The study reported a 29% cumulative live birth rate at two years among couples treated with NaProTechnology-based restorative reproductive medicine.²⁸

Boyle et al. (2022) reported a detailed case study in the Journal of Medical Case Reports documenting successful pregnancy after 16 years of infertility, three recurrent miscarriages, and eight failed IVF/ICSI embryo transfers. The couple achieved natural conception and delivered a healthy singleton after RRM evaluation identified and treated the underlying conditions.¹⁰

Boyle et al. (2018) published a cohort study in Frontiers in Medicine reporting healthy singleton pregnancies achieved through RRM after previous failed IVF. Among 403 couples with an average of 2.1 prior IVF attempts, the life-table live birth rate was 32.1%. Only 1 of 74 live births was a twin (1.4%), and 92% were born at 37 weeks or later.¹⁷

Boyle et al. (2025) published the first head-to-head RRM-versus-IVF comparison in the inaugural volume of the Journal of Restorative Reproductive Medicine. In a retrospective evaluation of 187 couples treated at NeoFertility Dublin in 2019, the crude live birth rate was 41% (77/187). The conception rate was 52%. Prematurity in singletons was 4.0%, compared to 11.8% in CDC data and 14.4% in SART-reported IVF singletons. Average time to conception was 12 months.²⁴

Sanchez-Mendez et al. (2025) published the largest NaProTechnology cohort study to date in Frontiers in Reproductive Health. The study followed 1,310 couples and reported a crude live birth rate of 35.3%. Using Kaplan-Meier survival analysis, the adjusted cumulative live birth rate reached 50.0% at 24 months and 62.1% at full follow-up (36+ months). This is the most methodologically detailed RRM outcomes study published to date.²⁵

What Surgical Approaches Does RRM Use?

Surgery in RRM treats the diagnosed condition rather than bypassing it. The scope includes endometriosis excision, ovarian cystectomy, adhesiolysis, tubal reconstruction, varicocele repair, and other procedures targeted to specific findings from the diagnostic workup. Surgical outcomes depend on disease severity, surgical completeness, and individual patient factors. In every case, the goal is restoring anatomy and function so the body can work as it should.

Endometriosis excision is the most studied surgical intervention in RRM. Long-term data distinguishes excision from ablation. Yeung et al. (2024), published in Acta Scientific Women's Health, reported a 2.5% rate of repeat surgery over ten years following optimal excision at a single tertiary referral center (620 patients).¹¹ Published literature on laser ablation reports symptom recurrence rates as high as 40% within five years, with long-term follow-up studies documenting repeat laparoscopy in over a quarter of patients. This difference is clinically significant. Excision removes the disease. Ablation burns the surface. The distinction determines whether women face repeated surgeries or sustained relief.

How Does the Cost of RRM Compare to IVF?

A single IVF cycle costs $15,000 to $30,000 in the United States. Most couples require two to three cycles, bringing average total costs to $40,000 to $60,000 or more. In the United States, only a minority of states mandate insurance coverage for IVF, leaving most couples to pay out of pocket.

RRM treatments cost considerably less. Because RRM diagnoses and treats specific medical conditions, many components may be billed under standard diagnostic and treatment categories: laparoscopy for endometriosis, hormonal testing for endocrine evaluation, progesterone for luteal phase support. Insurance coverage for these components varies significantly by plan, payer, and individual diagnosis. Katz et al. (2011), published in Fertility and Sterility, found that medication-only fertility treatments cost substantially less than IVF over an 18-month period.¹⁵ RRM's ability to bill through standard diagnostic categories creates a potential cost advantage for many couples, though the degree of coverage depends heavily on individual insurance circumstances.⁶

Are RRM Pregnancies Safer Than IVF Pregnancies?

RRM pregnancies are achieved through natural conception and are almost exclusively singletons. In Boyle et al. (2025), singleton prematurity was 4.0% and low birth weight was 5.3%. Multiple pregnancies occurred in only 2.5% of cases.²⁴ IVF pregnancies carry significantly higher rates across all of these measures: the CDC reports 11.8% singleton prematurity and 11.4% low birth weight among IVF-conceived pregnancies, with multiple gestation rates of 6 to 7% even with current transfer guidelines.¹⁶

IVF pregnancies pose increased risks to mothers as well, not only to infants. Bewley et al. (2011) documented that IVF is associated with higher rates of ectopic pregnancy, preeclampsia, placenta previa, and cesarean delivery.¹⁹ HFEA data confirms elevated rates of preterm birth, low birth weight, and perinatal complications among IVF-conceived pregnancies, including singletons.¹⁶ These are procedure-associated risks that exist independent of the underlying condition.

RRM pregnancies, because they result from natural conception after the underlying condition has been treated, do not carry these procedure-associated risks. Because the underlying disease is addressed before conception, women enter pregnancy with improved health status rather than conditions left active.

Where Is the RRM Evidence Base Headed?

The RRM evidence base is growing rapidly. It also has gaps that the field is actively working to close.

• Study design. Most RRM studies are observational cohort studies or case series, not randomized controlled trials (RCTs). This is a methodological limitation shared by much of fertility medicine, including IVF. But the reason RCTs do not yet exist in RRM is structural, not scientific. RCTs cost millions of dollars and are funded primarily by pharmaceutical companies with a patentable product to sell. RRM treats conditions with existing medications, surgical techniques, and diagnostic protocols. There is no blockbuster drug to justify the investment. The absence of RCTs reflects a funding structure, not an absence of evidence. Organizations like FACTS About Fertility and the IIRRM are working to close this gap.
• Sample sizes are increasing. The largest published RRM cohort, Sanchez-Mendez et al. (2025), followed 1,310 couples and reported adjusted cumulative live birth rates of 62.1%. Boyle et al. (2025) published the first direct RRM-versus-IVF comparison. The Journal of Restorative Reproductive Medicine launched its inaugural volume in 2025. The trajectory is clear: larger studies, stronger methodology, and a dedicated publication home for the research.
• Surgical capability is broader than critics assume. Bilateral tubal occlusion is frequently cited as a condition RRM cannot treat. RRM surgeons regularly perform selective hysterosalpingography (SHSG) and transcervical fallopian tube catheterization (TCFT), therapeutic procedures that open blocked fallopian tubes without IVF. SHSG is distinct from diagnostic HSG. It is an interventional procedure. Diagnostic HSG can produce false-positive bilateral occlusion readings in 20 to 30% of cases, often due to tubal spasm rather than true obstruction.⁹ With TCFT, over 75% of tubes with elevated intratubal pressures can achieve normal patency. Published intrauterine pregnancy rates after SHSG and TCFT range from 9 to 37%.⁹ That critics are unaware these procedures exist reflects gaps in their own training, not a limitation of RRM.
• Truly untreatable cases are rare. Non-obstructive azoospermia (testicular failure with no sperm production) is the most commonly cited condition where RRM alone cannot achieve pregnancy. It affects roughly 1% of all men. Among men with azoospermia, about 40% have obstructive causes that are surgically correctable. Even among non-obstructive cases, micro-TESE retrieves viable sperm in 30 to 60% of cases. The population for whom no RRM pathway exists is a small fraction of infertile couples.

The evidence already published supports RRM as effective, safe, and cost-accessible. The research trajectory points toward larger, more rigorous studies that will continue to strengthen the case.

What Do the Critics of RRM Actually Cite?

Major professional societies have published position statements, editorials, and open letters raising concerns about RRM. A review of these documents reveals a consistent pattern: the critiques are structural (no RCTs, no ABMS sub-board, ideological framing) rather than data-driven. The institutional position papers, fact sheets, and advocacy communications collectively cite zero peer-reviewed RRM outcome studies to support the claim that RRM lacks evidence.

The most common demand is for randomized controlled trials. This standard is not applied to IVF, which built its clinical practice on observational data, case series, and registry outcomes for decades before any RCTs were conducted. IVF has never been required to prove superiority over expectant management in a randomized trial before being offered to patients. Demanding a standard of one field that was never required of the other is not scientific rigor. It is a double standard.

Another common claim is that reproductive endocrinologists already do everything RRM does. The data says otherwise. In Boyle et al. (2025), "unexplained infertility" dropped from 24% to 1% after RRM workup. If REIs were already performing this level of diagnostic evaluation, those conditions would have been identified before the couples arrived at an RRM clinic. In a clinical series of patients whose prior laparoscopy by another surgeon was reported as normal, near-contact re-examination found pelvic disease in 93.5% of cases.⁹ Selective HSG for tubal occlusion is not part of REI training or practice. It is a procedure that exists in the RRM surgical toolkit and virtually nowhere else in reproductive medicine. REIs do not use cycle-timed serial hormone evaluation and do not routinely diagnose or treat conditions like chronic endometritis or hypoandrogenism that RRM clinicians identify and resolve. The claim that this workup is already standard of care is contradicted by the patients who arrive at RRM clinics with years of undiagnosed disease.

The publicly available advocacy documents do not cite or engage with Boyle et al. (2018), Boyle et al. (2025), Sanchez-Mendez et al. (2025), or James et al. (2021). The newest and largest data in the field remains unaddressed. Patients and clinicians deserve to evaluate the actual published data, not a characterization of the field that ignores it.

Why Don't More Doctors Know About RRM?

Most clinicians have never been trained in cycle-based diagnosis. That is not a reflection of the evidence. It is a reflection of how reproductive medicine is taught and funded.

Medical education. FABMs account for just 4% of all family planning mentions across evaluated U.S. medical school curricula, compared to nine times more coverage for hormonal contraception. Over 80% of family medicine residents report receiving less than one hour of FABM education during their entire residency.⁵³⁶ Clinicians who are never taught to read cycle data cannot use it diagnostically. The result is a generation of OBGYNs who default to suppressive medications not because the evidence demands it, but because no alternative framework was ever presented.⁷

Research funding. Women's health research has been systematically underfunded relative to disease burden. Endometriosis receives 18 cents per dollar of what its disease burden warrants. PCOS receives $9 to $10 million per year from NIH despite affecting an estimated 13% of reproductive-age women. A 2024 National Academies of Sciences report found that only 8.8% of NIH grant spending from 2013 to 2023 targeted women's health research, and that share has been declining even as the overall NIH budget has grown.³⁷³⁸

Unvalidated technology. The growing femtech industry offers women data-driven reproductive health tools, but much of the underlying science has not been validated against the established biomarker research that RRM clinicians rely on.⁷ Cycle-tracking apps that estimate ovulation from algorithms without validated biomarker inputs are not equivalent to clinically validated charting methods taught by trained instructors. Women deserve tools built on validated science, not marketing.

The published evidence supports RRM as effective, safe, and cost-accessible for couples facing infertility and for individuals managing reproductive health conditions across the lifespan. RRM improves the health of women and men even when pregnancy is not the goal or the outcome. Couples who complete an RRM evaluation leave with a diagnosis, a treatment record, and a documented understanding of their own reproductive function. That knowledge belongs to them permanently.⁷

What to Expect: The RRM Experience

RRM is not a single appointment or a one-time procedure. It is an active treatment relationship between a patient and clinician, built around the patient's own biomarkers and adjusted over time. Here is what that looks like in practice.

Before the First Visit: Charting

Most RRM clinicians ask patients to begin charting one to three months before the first consultation. The patient tracks daily observations: mucus patterns, bleeding, pain, premenstrual symptoms. By the time the first appointment arrives, the chart contains real data the clinician can read. A teenager tracking worsening periods sees the pattern on paper for the first time. A woman who has been dismissed for years arrives with documentation that speaks for itself.

The First Appointment

The clinician sits down with the chart. They walk through it cycle by cycle, asking questions about what the patient observed and when. They take a full medical history. Then they order targeted tests: bloodwork timed to specific phases of the next cycle, imaging if indicated, semen analysis for the male partner if infertility is the concern. The patient leaves with a concrete testing schedule, not a generic referral.

Diagnosis: One to Three Cycles

Lab results come back tied to specific cycle days. The clinician reads them against the chart. Most patients receive a specific, named diagnosis: luteal phase deficiency, endometriosis, a PCOS subtype, thyroid dysfunction, chronic endometritis, or a combination. Some diagnoses are straightforward. Others require a second cycle of testing or diagnostic laparoscopy to confirm. The process is methodical, not rushed.

Treatment and Monitoring

Treatment is matched to the diagnosis. It may include hormonal support, surgery, metabolic intervention, or a combination. When a male factor is identified, the man receives his own targeted treatment plan. Nothing is generic. Each cycle, the patient charts again. The clinician reviews new data each cycle and adjusts based on what it shows. Patients see their own progress in the chart. They are active participants in their care, not passive recipients of a protocol they cannot see or understand.

How Long Does RRM Take?

Timelines depend on diagnosis and treatment complexity. Hormonal conditions may respond within a few cycles. Surgical cases require recovery before the full effect is measurable. In the Sanchez-Mendez 2025 cohort, median treatment duration was 10.9 months, with cumulative outcomes continuing to improve through 36 months.²⁵ Patients should plan for an active treatment window of 6 to 18 months. What they gain along the way (a diagnosis, treated disease, a detailed record of their own physiology) has value regardless of the final outcome.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.

How Much Does RRM Cost?

RRM costs vary by diagnosis and treatment plan. A patient with a hormonal imbalance managed through cycle-timed bloodwork and targeted medication will have different costs than a patient who needs excision surgery for endometriosis. There is no single price tag.

Insurance Coverage

RRM treats diagnosed medical conditions. That means many of its components can be submitted to insurance as treatment for a specific disease, not as an elective procedure.

That said, insurance billing for RRM is not simple. Coverage varies by plan, by state, and by insurer. Some components are covered routinely. Others require prior authorization, appeals, or out-of-network negotiation. Many RRM clinicians are not in-network for every plan. Patients should expect to advocate for themselves and work closely with their clinician's billing staff.

The insurance system was not designed with RRM in mind. Navigating it takes effort. But the underlying model, treating a diagnosed disease, gives patients a foundation for coverage that elective or bypass procedures do not have.

Legislative Progress

The policy landscape is shifting. In 2025, Arkansas became the first U.S. state to mandate insurance coverage for restorative reproductive medicine.¹² The RESTORE Act (H.R. 3589), introduced in the 119th Congress, would expand federal recognition of cause-based reproductive treatment.²⁰ These developments reflect growing recognition that treating the underlying condition deserves a place in coverage policy.

What to Ask Your Insurer

• Is diagnostic testing covered when ordered for a named condition (e.g., endometriosis, PCOS, thyroid disorder)?
• Is gynecologic surgery covered as a medical procedure, separate from any fertility benefit?
• What are my out-of-network benefits?
• Does my state mandate coverage for reproductive health diagnosis or treatment?

How Do Doctors Train in RRM?

RRM is a growing field with structured training pathways for charting instructors, medical students, practicing clinicians, and allied health professionals. The scope covers more than fertility. Clinicians enter RRM to better manage menstrual disorders, hormonal dysfunction, pelvic pain, and chronic conditions across the reproductive lifespan. Here is how the training ecosystem is structured.

What Is a FertilityCare Practitioner?

A FertilityCare Practitioner (FCP) teaches patients to observe and record their biomarkers using the Creighton Model FertilityCare System. The program spans 13 months: two in-person education phases at the Saint Paul VI Institute or an AAFCP-accredited program, separated by supervised remote practica in which the student teaches real clients. Certification is through the American Academy of FertilityCare Professionals (AAFCP). NPs, PAs, nurse midwives, and pharmacists can pursue a combined FCP/Medical Consultant track. FCPs are the front line of RRM. They generate the charting data that clinicians depend on for diagnosis and cycle-timed treatment decisions. Without accurate chart data, clinicians are working without the information they need.

What Is a NaProTechnology Medical Consultant?

A Medical Consultant is a physician certified to interpret Creighton Model charts and manage medical treatment using NaProTechnology protocols. The program runs six months through the Saint Paul VI Institute: two in-person immersions (an eight-day Education Phase I and a six-day Education Phase II) with a supervised remote practicum between them. The curriculum covers NaProTechnology pathophysiology, luteal and follicular phase deficiencies, hormone evaluation, progesterone therapy, and introductory surgical NaProTechnology. The program earns up to 67.75 AMA PRA Category 1 CME credits through Creighton University. This is a medical management credential, not a surgical one. Medical Consultants prescribe cycle-timed medications and refer for surgical intervention when needed.

What Does the NaProTechnology Surgical Fellowship Cover?

The St. John Paul II Fellowship in Medical and Surgical NaProTechnology is a one-year, full-time, salaried position at the Saint Paul VI Institute. It requires board certification or eligibility in OBGYN and a personal interview with the Director. The fellowship covers reproductive endocrinology, reconstructive pelvic surgery, laser surgery, microsurgery, adhesion prevention, selective HSG for tubal occlusion, tubal reconstruction, and endometriosis excision. Fellows earn over 120 ACOG cognate CME credits per year and complete a mandatory research project. This is the most intensive credential in the field. It produces surgeons capable of managing complex, multi-system reproductive conditions that the Medical Consultant designation does not cover.

What Does RRM Academy Offer for Clinical Education?

RRM Academy (rrmacademy.org) is an online education platform offering courses for both patients and healthcare professionals. Course topics include endometriosis, surgical technique, postpartum health, and the fundamentals of restorative reproductive medicine. RRM Academy makes fellowship-level expertise accessible to the broader medical community through structured online coursework, without requiring full fellowship enrollment.

What Is FEMM and the Reproductive Health Research Institute (RHRI)?

FEMM's research arm, the Reproductive Health Research Institute (RHRI), provides Medical Management training for clinicians through a two-step pathway. The Intro course (20 AAFP CME credits, online, self-paced) covers FEMM research foundations and reproductive physiology. The Masterclass (18 AAFP CME credits, offered live in-person and online annually) covers RHRI diagnostic and treatment protocols for ovulatory dysfunction, PCOS, thyroid imbalances, and infertility, with protocol textbooks included. Clinicians who complete both steps (38 total CME credits) earn the Certified FEMM Medical Provider designation and are enrolled as RHRI Fellows. Advanced topic courses (8 to 12 CME each) cover obesity, mental health, ovarian aging, and other subjects. Training is available at femmhealth.org.

What Is FACTS and Who Is It For?

FACTS (Fertility Appreciation Collaborative to Teach the Science) offers a 13-part AAFP-accredited professional CME course (up to 16 credits per part) covering FABMs, medical applications, RRM protocols, lifestyle and fertility, femtech evaluation, and reproductive health across the lifespan. Parts can be taken individually or as a full course. FACTS also offers Georgetown-approved medical student and resident electives (two-week online rotations with clinical preceptorship), an advanced NeoFertility Medical Consultant cohort co-taught with Dr. Phil Boyle, and an annual conference with hands-on workshops. FACTS does not certify charting instructors. It focuses entirely on medical and clinician education.²¹

What Is NeoFertility Training?

NeoFertility, founded by Dr. Phil Boyle, offers the Clinical Mastery Program: an on-demand course (15 CME credits) with monthly live case reviews covering NeoFertility diagnostic and treatment protocols for infertility, recurrent miscarriage, and hormonal conditions. The NeoFertility approach uses any FABM chart as the clinical foundation, not exclusively the Creighton Model. The same curriculum is also available through the IIRRM CME platform and through FACTS as an advanced cohort. Monthly case reviews with Dr. Boyle are available separately for $10/month.

What Is the IIRRM?

The IIRRM (International Institute for Restorative Reproductive Medicine) is the professional home for the global RRM community. It provides international credentialing, hosts the annual International Clinical and Scientific Congress, runs monthly Grand Rounds and case discussions, publishes the Journal of Restorative Reproductive Medicine, and maintains a provider referral network. IIRRM's AAFP-accredited CME catalog includes courses covering andrology and male reproductive health, NeoFertility protocols, and a 55-credit RRM Approach to PCOS (RRMaP) program that trains clinicians in PCOS pathophysiology, diagnostics, and treatment across 14 modules. Additional courses in ultrasound and ovulation optimization are in development.¹

What Are the Most Common Myths About Restorative Reproductive Medicine?

RRM challenges assumptions that many patients and clinicians take for granted. That generates pushback. Some of it comes from genuine misunderstanding. Some comes from professional organizations with competing interests. Here are the most common objections and what the evidence actually shows.

How Do I Get Started with Restorative Reproductive Medicine?

Getting started depends on who you are and what you need. Below are three pathways: one for patients and individuals seeking care, one for healthcare professionals, and one for researchers.

For Patients and Individuals

1. Learn a validated cycle-charting method. Charting provides the diagnostic data that RRM clinicians rely on. Options include the Creighton Model FertilityCare System, Marquette Method, FEMM, Billings Ovulation Method, and SymptoThermal methods. Find a certified instructor through the training organization for your method:
   • FertilityCare Centers of America (Creighton Model)
   • Marquette Method Professionals Association
   • FEMM Health
   • FACTS directory (SymptoThermal, CCL, and others)
   No charted cycles are needed before contacting an instructor. That is where you start.
2. Find an RRM-trained clinician. The IIRRM referral network connects you with credentialed providers. Natural Womanhood's provider directory is another resource. If you use a specific charting method, ask your instructor for provider recommendations within that method's network. You can identify and contact a clinician while still in early charting. Most patients need 1 to 3 charted cycles before their first visit, not before first contact.²²
3. Prepare for your first appointment. Bring your charted cycles, complete medical history, prior lab and imaging results, and a list of questions. If you have a partner and your condition may involve shared factors, it may be helpful for your partner to attend as well.²⁷
4. Educate yourself. Browse free courses at RRM Academy to understand the approach, the conditions it treats, and what to expect from treatment. Read clinician commentaries for clinical perspective. Review our frequently asked questions and the RRM glossary for definitions of clinical terms. Knowledge helps you advocate for your own care.

For Healthcare Professionals

• Start with online education. RRM Academy courses cover endometriosis, hormonal evaluation, surgical principles, and the fundamentals of cycle-based care.
• Explore IIRRM credentialing. The International Institute for Restorative Reproductive Medicine offers professional credentialing and hosts international conferences with CME credit.
• Engage with FACTS. FACTS About Fertility offers a structured clinical elective for medical students and residents, and hosts an annual conference with CME credit open to practicing clinicians across disciplines.²¹
• Pursue advanced training. For clinicians seeking the deepest clinical preparation, fellowship-level training through the Saint Paul VI Institute covers advanced surgical technique, hormonal protocols, and the full scope of cycle-based diagnosis and treatment. This pathway is NaProTechnology-specific.⁹

For Researchers

• Browse the RRM Research Library. Our Research Library indexes over 3,000 publications relevant to restorative reproductive medicine, fertility awareness-based methods, and related clinical science. Citations can be exported directly to Zotero.
• Submit research. The Journal of Restorative Reproductive Medicine is an open-access, peer-reviewed journal published by IIRRM with continuous rolling publication.
• Join the research community. IIRRM membership connects researchers and clinicians across 52 countries. Members can participate in the IIRRM Journal Club and quarterly Research Updates webinars. The IIRRM Congress and the annual FACTS conference both accept research presentations and poster abstracts.

RRM care begins with charting instruction and builds from there. Whether your goal is treatment, clinical practice, or research.

Frequently Asked Questions

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation. Statistics represent published research averages, not guarantees of individual outcomes.